Adenosine A2B receptor: novel anti-cancer therapeutic implications

References

[1] Ohta A.Extracellular adenosine-mediated modulation of regulatory T cells..Front Immunol2014;5:304 PMCID:PMC4091046

[2] Borea PA,Merighi S.Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?.Trends Pharmacol Sci2016;37:419-34

[3] Sun Y.Adenosine A2B receptor: from cell biology to human diseases..Front Chem2016;4:37 PMCID:PMC4995213

[4] Sorrentino C.Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target..J Cancer Metastasis Treat2017;3:127-38

[5] Ryzhov S,Goldstein AE,Blackburn MR,Dikov MM.Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells..J Immunol2011;187:6120-9 PMCID:PMC3221925

[6] Haskó G,Németh ZH,Pacher P.A(2B) adenosine receptors in immunity and inflammation..Trends Immunol2009;30:263-70 PMCID:PMC2756472

[7] Aherne CM,Collins CB,McNamee EN,Rapp CR,Bayless A,Glover LE,Jedlicka P,de Zoeten EF,Eltzschig HK.Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis..Mucosal Immunol2015;8:1324-38 PMCID:PMC4598274

[8] Merighi S,Vincenzi F,Borea PA.A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway..Pharmacol Res2017;117:9-19

[9] Novitskiy SV,Zaynagetdinov R,Huang Y,Blackburn MR,Carbone DP,Dikov MM.Adenosine receptors in regulation of dendritic cell differentiation and function..Blood2008;112:1822-31 PMCID:PMC2518889

[10] Whiteside TL.Targeting adenosine in cancer immunotherapy: a review of recent progress..Expert Rev Anticancer Ther2017;17:527-35

[11] Mittal D,Stannard K,Teng MW,Stagg J.Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor..Cancer Res2014;74:3652-8

[12] Allard B,Smyth MJ.TTargeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs..Clin Cancer Res2013;19:5626-35

[13] Iannone R,Maiolino P,Morello S.Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model..Am J Cancer Res2014;4:172-81 PMCID:PMC3960454

[14] Beavis PA,Henderson MA,Allard B,Kershaw MH,Darcy PK.Adenosine receptor 2A blockade increases the efficacy of Anti-PD-1 through enhanced antitumor T-cell responses..Cancer Immunol Res2015;3:506-17

[15] Ma DF,Nakazawa T,Mochizuki K,Yamane T.Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells..Hum Pathol2010;41:1550-7

[16] Desmet CJ,Prieur A,Visser NL,Smit MA,Laoukili J,Rodenko B,Evers B,Ajouaou A,van Vliet M,Wessels LF.Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis..Proc Natl Acad Sci U S A2013;110:5139-44 PMCID:PMC3612632

[17] Kasama H,Kasamatsu A,Koyama T,Ogawara K,Shiiba M,Uzawa K.Adenosine A2b receptor promotes progression of human oral cancer..BMC Cancer2015;15:563 PMCID:PMC4520274

[18] Zhou Y,Deng F,Tong G,Liu J,Tang Y,Dai Y.The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway..Oncotarget2017;8:48755-68

[19] Mittal D,Barkauskas D,Kalimutho M,Caramia F,Stagg J,Loi S.Adenosine 2B receptor expression on cancer cells promotes metastasis..Cancer Res2016;76:4372-82

[20] Vecchio EA,Gregory KJ,White PJ.Ligand-independent adenosine A2B receptor constitutive activity as a promoter of prostate cancer cell proliferation..J Pharmacol Exp Ther2016;357:36-44

[21] Loi S,Haibe-Kains B,Darcy PK,Stagg J.CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer..Proc Natl Acad Sci U S A2013;110:11091-6 PMCID:PMC3704029

[22] Mølck C,Failla LM,Pascussi JM,Stewart G.The A2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism..Cancer Lett2016;383:135-43